Triple Negative Breast Cancer (TNBC), the most aggressive subtype of breast cancer, is characterized by the absence of hormone receptors usually targeted by hormone therapies like Tamoxifen. The gene discussed is NR4A1; the disease is triple-negative breast carcinoma.